1. Home
  2. YOU vs TVTX Comparison

YOU vs TVTX Comparison

Compare YOU & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Secure Inc.

YOU

Clear Secure Inc.

SELL

Current Price

$59.08

Market Cap

4.6B

Sector

Technology

ML Signal

SELL

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

SELL

Current Price

$52.42

Market Cap

4.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
YOU
TVTX
Founded
2010
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.7B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
YOU
TVTX
Price
$59.08
$52.42
Analyst Decision
Buy
Strong Buy
Analyst Count
6
15
Target Price
$58.17
★ $75.14
AVG Volume (30 Days)
1.2M
★ 2.1M
Earning Date
11-04-2026
11-02-2026
Dividend Yield
★ 1.68%
N/A
EPS Growth
N/A
★ 92.89
EPS
★ N/A
N/A
Revenue
★ $900,779,000.00
N/A
Revenue This Year
$23.34
$55.24
Revenue Next Year
$14.49
$43.78
P/E Ratio
$20.59
★ N/A
Revenue Growth
★ 16.91
N/A
52 Week Low
$30.98
$22.59
52 Week High
$69.07
$68.73

Technical Indicators

Market Signals
Indicator
YOU
TVTX
Relative Strength Index (RSI) 68.22 33.18
Support Level $46.91 $41.75
Resistance Level $50.35 $59.93
Average True Range (ATR) 1.45 2.58
MACD 0.29 0.17
Stochastic Oscillator 82.61 43.17

Price Performance

Historical Comparison
YOU
TVTX

About YOU Clear Secure Inc.

Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in creating a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports, helping to make the travel experience safe and easy. The Company's operations are mainly focused on growing and maintaining its secure identity network across multiple offerings in both aviation and non-aviation channels.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: